Hepatitis B vaccine immunogenic, safe in diabetes patients
The hepatitis B vaccine was immunogenic in adults with type 2 diabetes and had a safety profile similar to that of control subjects in a manufacturer-sponsored phase-IV trial published in Human...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Vaccines